Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TNGX
TNGX logo

TNGX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TNGX News

RTW Investments Increases Stake in Tango Therapeutics

2d agoNASDAQ.COM

RTW Investments Acquires 11.8 Million Shares of Tango Therapeutics

2d agoFool

Boxer Capital Acquires $17.55 Million Stake in Corvus Pharmaceuticals

May 17 2026Yahoo Finance

Tango Therapeutics Stock Recovery Opportunity Amid Analyst Upgrades

May 15 2026stocktwits

Tango Therapeutics Q1 Earnings Miss Expectations

May 13 2026seekingalpha

Tango Therapeutics Grants Stock Options and RSUs to Executives

May 04 2026Newsfilter

Tango Therapeutics Appoints New CFO and Executives to Accelerate Growth

Apr 15 2026Newsfilter

Revolution's Cancer Drug Shows Promising Results in Trials

Apr 13 2026stocktwits

TNGX Events

05/15 12:10
Tango Therapeutics Stock Falls 19.7% to $19.98
Tango Therapeutics is down -19.7%, or -$4.89 to $19.98.
05/15 10:10
Tango Therapeutics Shares Drop 14.9% to $21.16
Tango Therapeutics is down -14.9%, or -$3.71 to $21.16.

TNGX Monitor News

Tango Therapeutics Q1 Earnings Miss Expectations

May 15 2026

Tango Therapeutics stock declines amid market weakness

Apr 28 2026

Tango Therapeutics Partners with Erasca for Clinical Trial of ERAS-0015

Mar 05 2026

TNGX Earnings Analysis

No Data

No Data

People Also Watch